Company / SG&A per Share
Centessa Pharmaceuticals plc SG&A per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$0.34
FY2025
5-year range
$0.34 / $0.59
FY2021-FY2025
Trend
-11.7%
vs FY2024
Sector context
#184 of 210
Health Care
What the data says
Centessa Pharmaceuticals plc's sg&a per share of $0.34 is lower than 88% of companies in the Health Care sector (FY2025). SG&A per Share has declined for 3 consecutive years, from $0.59 in FY2022 to $0.34 in FY2025.
Based on SEC 10-K filings.
0.34 in FY2025 with a 3-year CAGR of -17.0%.
Improved from $0.57 to $0.34 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- -17.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 12% in Health CareTop 12% of 210This company $0.34 Sector average $40.71
▼
-99.2% below sector average
Key checks
Key Insights
- Centessa Pharmaceuticals plc's sg&a per share has declined for 3 consecutive years.
- In FY2025, sg&a per share decreased 11.7% year-over-year.
- Ranks #184 out of 210 companies in the Health Care sector.
- Peak sg&a per share was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score 0.80 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.34 | -11.7% |
| FY2024 | $0.38 | -32.4% |
| FY2023 | $0.57 | -4.1% |
| FY2022 | $0.59 | +3.6% |
| FY2021 | $0.57 | - |
| FY2020 | - | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026